This firm develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. And news of a potential licensing agreement is sending shares soaring in morning...

To read the full story on AllPennyStocks.com, click here.

BioRestorative Therapies (NASDAQ:BRTX)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos BioRestorative Therapies.
BioRestorative Therapies (NASDAQ:BRTX)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos BioRestorative Therapies.